Snowball logo
logo
1093_logo

CSPC Pharmaceutical Group Limited

HK$8.70-HK$0.165Β  (1.86%)
πŸ’‘ Click on a row in the table to make it appear on the graph
πŸ“Š Compare financials of multiple companies on the same chart
This feature is available with our premium plans. Upgrade to unlock the full potential of Snowball Analytics and be on top of your investments!
20212022202320242025TTM
Revenue
Total revenue
27,406.127,893.131,470.727,757.925,332.950,494.3
COGS
6,620.57,826.49,279.58,334.88,715.915,438.3
Gross Profit
20,785.620,066.722,191.219,423.116,61735,055.9
Operating Expenses & Income
Operating Income
6,141.96,119.77,005.55,122.23,868.212,365.1
Total Operating Expenses
14,643.713,94715,185.714,300.812,748.824,969.8
R&D Expenses
3,375.83,594.34,833.54,966.75,658.48,692.7
Selling General & Admin Expenses
1,238.91,1721,308.81,079.5825.54,239.8
Earnings from Continuing Operations
Interest Expense
(7.664)(21.98)(25.9)(41.04)(37.6)(51.03)
Interest Income
14.7835.5780.09125.191.0494.47
Income Tax Expense
1,139.81,217.41,317.51,186.4907.61,969
Net Income
Net Income
5,512.55,492.15,877.24,141.33,781.610,784.6
Supplemental
EBIT
6,719.36,872.67,474.45,465.53,868.2-
EBITDA
7,568.87,815.58,589.36,7445,241.2-
In millions of HKD, except % and values per 1 share